Fuji Pharma Co Debt 2025

Fuji Pharma Co Aktienanalyse

What does Fuji Pharma Co do?

Fuji Pharma Co Ltd is a Japanese company specializing in the healthcare industry. The company was founded in 2001 and is headquartered in Tokyo, Japan. It is listed on the Tokyo Stock Exchange and employs over 1,000 employees. Fuji Pharma's business model is to provide its customers with innovative and high-quality products that contribute to improving health and well-being. The company specializes in several business areas, including the development, manufacturing, and marketing of pharmaceutical products, production of OEM products for other companies, and manufacturing of dietary supplements and cosmetics. An important area for Fuji Pharma is the development and production of pharmaceuticals. The company ensures that its medications meet the highest requirements and international standards. This includes research and development of new products. The company has its own research department specializing in the development of medications that can be used in serious diseases such as cancer, diabetes, and cardiovascular diseases. In addition, Fuji Pharma is also involved in the production of OEM products for other companies. The company ensures the manufacture of medications and medical products for other pharmaceutical companies, meeting the highest quality standards and customer requirements. Fuji Pharma is proud to be a trusted partner for its customers and provides its services according to the requirements of its customers. In addition to these two divisions, Fuji Pharma also produces dietary supplements and cosmetics for the domestic and international markets. These products are designed for consumers who want to improve their health and well-being. The company places great emphasis on the development of natural and safe ingredients for its products and ensures the highest standards of quality and safety. Fuji Pharma has also specialized in the Japanese market for medical devices, particularly in the field of home respiratory devices. The company has developed a new generation of respiratory therapy devices that are safe and easy to use, providing better well-being and quality of life for patients with respiratory diseases. In addition to its business areas, Fuji Pharma also has various products in its portfolio that are known for their quality and effectiveness. One such product is "Efil," a medication used in the treatment of erectile dysfunction disorders. The medication is available in Japan and other Asian countries and has already been used by over 200,000 patients. Fuji Pharma continuously strives to improve its research and development activities and develop new innovative products and services for the healthcare industry. The company aims to bring its products and services to the international market and satisfy its customers in Japan and worldwide. Fuji Pharma Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Fuji Pharma Co's Debt Structure

Fuji Pharma Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Fuji Pharma Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Fuji Pharma Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Fuji Pharma Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Fuji Pharma Co stock

What is the debt of Fuji Pharma Co this year?

Fuji Pharma Co has a debt level of 24,757 JPY this year.

What was the debt of Fuji Pharma Co compared to the previous year?

The debt of Fuji Pharma Co has increased by -7.41% compared to the previous year dropped.

What are the consequences of high debt for investors in Fuji Pharma Co?

High debt can pose a risk for investors of Fuji Pharma Co, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Fuji Pharma Co?

Low debt means that Fuji Pharma Co has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Fuji Pharma Co affect the company?

An increase in debt of Fuji Pharma Co can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Fuji Pharma Co affect the company?

A reduction in debt of Fuji Pharma Co can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Fuji Pharma Co?

Some factors that can influence the debt of Fuji Pharma Co include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Fuji Pharma Co so important for investors?

The debts of Fuji Pharma Co are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Fuji Pharma Co take to change the debt?

To change the debt, Fuji Pharma Co can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Fuji Pharma Co pay?

Over the past 12 months, Fuji Pharma Co paid a dividend of 42.5 JPY . This corresponds to a dividend yield of about 2.66 %. For the coming 12 months, Fuji Pharma Co is expected to pay a dividend of 44.61 JPY.

What is the dividend yield of Fuji Pharma Co?

The current dividend yield of Fuji Pharma Co is 2.66 %.

When does Fuji Pharma Co pay dividends?

Fuji Pharma Co pays a quarterly dividend. This is distributed in the months of April, October, April, October.

How secure is the dividend of Fuji Pharma Co?

Fuji Pharma Co paid dividends every year for the past 17 years.

What is the dividend of Fuji Pharma Co?

For the upcoming 12 months, dividends amounting to 44.61 JPY are expected. This corresponds to a dividend yield of 2.79 %.

In which sector is Fuji Pharma Co located?

Fuji Pharma Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Fuji Pharma Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Fuji Pharma Co from 12/1/2025 amounting to 22.5 JPY, you needed to have the stock in your portfolio before the ex-date on 9/29/2025.

When did Fuji Pharma Co pay the last dividend?

The last dividend was paid out on 12/1/2025.

What was the dividend of Fuji Pharma Co in the year 2024?

In the year 2024, Fuji Pharma Co distributed 37 JPY as dividends.

In which currency does Fuji Pharma Co pay out the dividend?

The dividends of Fuji Pharma Co are distributed in JPY.